Baolingbao Biology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 657.77 million compared to CNY 554.9 million a year ago. Revenue was CNY 657.77 million compared to CNY 554.9 million a year ago. Net income was CNY 42.72 million compared to CNY 8.83 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.02 a year ago. Diluted earnings per share from continuing operations was CNY 0.11 compared to CNY 0.02 a year ago.